Access
This article is part of Nature's premium content.
Published online 18 March 2009 | 458, 270 (2009) | doi:10.1038/458270a
News
Roche vows to keep Genentech culture
It will be business as usual despite the merger, say bosses.
An era has ended for the biotechnology industry with the full merger of biotech pioneer Genentech, of South San Francisco, and Swiss pharmaceutical giant Roche, based in Basel.
The deal, announced on 12 March, ends Roche's eight-month pursuit of Genentech.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
